• 14/08/2020

    Successful KNCV-led TB REACH-projects test Digital Adherence Technologies in the fight against TB

    Since 2018, KNCV has rolled-out Digital Adherence Technology (DAT) demonstration projects in the Philippines and Tanzania. These TB REACH projects…

    Lees meer
  • 14/08/2020

    The story of Angelito: “99DOTS helped me get cured of TB”

    My name is Angelito* and I am a TB survivor from Mandaluyong City, Philippines. Angelito in his…

    Lees meer
  • 03/08/2020

    European approval for new drug against highly resistant TB

    The European Commission has given conditional market authorisation for the three-drug, six-month, all-oral regimen for the treatment of highly resistant…

    Lees meer
  • 30/07/2020

    Mustapha Gidado new Executive Director of KNCV

    Dr. Mustapha Gidado is taking office as the new Executive Director of KNCV Tuberculosis Foundation. He succeeds Kitty van Weezenbeek,…

    Lees meer
  • 22/07/2020

    Summary to the KNCV Webinar: Impact of COVID-19: Hear the perspective of TB/MDR-TB patients and front line health care workers

    On Thursday 16th of July 2020 KNCV held its next webinar in the KNCV Webinar Series: ‘Contact Investigation for COVID-19:…

    Lees meer
  • 16/07/2020

    KNCV takes over TIME implementation

    KNCV Tuberculosis Foundation is taking over implementation of the TIME modelling framework from the London School of Hygiene and Tropical…

    Lees meer
  • 13/07/2020

    Summary & video of the KNCV Webinar: Contact Investigation for COVID-19: Lessons from TB Control Programs – Part 2

    On 2 July 2020 KNCV held its third webinar in the KNCV Webinar Series: ‘Contact Investigation for COVID-19: Lessons from…

    Lees meer
  • 13/07/2020

    KNCV partners with MSH for Eliminate TB from Ethiopia (ETBE) Project

    The US Agency for International Development (USAID) has granted the Eliminate TB from Ethiopia (ETBE) Project. Management Sciences for Health…

    Lees meer
  • 03/07/2020

    Summary to the KNCV Webinar: Contact Investigation for COVID-19: Lessons from TB Control Programs

    On 25 June 2020 KNCV held its second webinar in the KNCV Webinar Series: ‘Contact Investigation for COVID-19: Lessons from…

    Lees meer
  • 25/06/2020

    Summary and link to the KNCV Webinar ‘Infection prevention and control for COVID-19’

    On 18 June 2020 KNCV kicked off the new KNCV Webinar Series starting with the topic ‘Infection prevention and control…

    Lees meer
  • 14/06/2020

    KNCV Tuberculosis Foundation sounds the alarm: COVID-19 will cause even more TB deaths

    he coronavirus has grabbed the attention of the world. Yet with 4,000 deaths a day worldwide, tuberculosis (TB) is holding…

    Lees meer
  • 28/05/2020

    Executive Director Kitty van Weezenbeek leaves KNCV

    Kitty van Weezenbeek has said goodbye as executive director of KNCV Tuberculosis Foundation. After having held this position for seven…

    Lees meer
  • 28/05/2020

    Looking back at five successful years of Challenge TB

    The KNCV-led, USAID-funded Challenge TB (CTB) project operated from 2014 to 2019 in 24 countries and two regions. The overall…

    Lees meer
  • 08/05/2020

    Martin Boeree has been appointed professor

    Effective 1 April 2020, Martin Boeree has been appointed professor of Clinical Tuberculosis and other Mycobacterial Diseases at Radboud University/Radboud…

    Lees meer
  • 01/05/2020

    Dr. Mustapha Gidado becomes acting interim Executive Director of KNCV

    We are very pleased to announce that from 1 May 2020 onwards, Dr. Mustapha Gidado is acting as interim Executive…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi


KNCV Tuberculosefonds
Maanweg 174
2516 AB Den Haag
+31 70 416 7222


Postal address

Postbus 146
2501 CC Den Haag

More information


De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.